Skip to main content
Clinical Trials/NCT06432894
NCT06432894
Recruiting
N/A

Performance Evaluation of Analgesia Nociception Index (ANI) in Patients Under General Anaesthesia With Remimazolam: a Prospective Observational Study

Catholic Kwandong University1 site in 1 country30 target enrollmentApril 23, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pain Measurement
Sponsor
Catholic Kwandong University
Enrollment
30
Locations
1
Primary Endpoint
ANI values
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to determine whether Analgesia Nociception Index (ANI) can effectively reduce the dose of opioid in patients who underwent general anesthesia using remimazolam.

Registry
clinicaltrials.gov
Start Date
April 23, 2024
End Date
June 11, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jungmin Lee

Assistant Professor

Catholic Kwandong University

Eligibility Criteria

Inclusion Criteria

  • aged 20-79 years under general anaesthesia with remimazolam
  • scheduled to undergo robotic surgery
  • in American Society of Anesthesiologists physical class 1, 2 or 3
  • voluntarily agree in writing to participate in this clinical study

Exclusion Criteria

  • Conditions affecting the autonomic nervous system
  • other conditions or disease that may cause acute or chronic pain
  • the NRS before induction of anesthesia is 1 or over
  • When taking medications that may affect the autonomic nervous system
  • In other cases where the investigator deems the subject unsuitable for this trial

Outcomes

Primary Outcomes

ANI values

Time Frame: During Surgery (at the points of intubation, skin incision, CO2 insufflation, TOF stimulation, and hemodynamic change)

A value indicating the degree of pain calculated by ANI's algorithm

Secondary Outcomes

  • Heart Rate (HR) change(Every 2 seconds for 2.5 minutes before and Every 2 seconds for 2.5 minutes after pain stimulation)
  • Blood Pressure change(Every 2 seconds for 2.5 minutes before and Every 2 seconds for 2.5 minutes after pain stimulation)
  • Remimazolam infusion rate(During Surgery (at the points of intubation, skin incision, CO2 insufflation, TOF stimulation, and hemodynamic change))
  • Patient state index (PSI) change(Every 2 seconds for 2.5 minutes before and Every 2 seconds for 2.5 minutes after pain stimulation)
  • Effect site concentration of remifentanil(During Surgery (at the points of intubation, skin incision, CO2 insufflation, TOF stimulation, and hemodynamic change))

Study Sites (1)

Loading locations...

Similar Trials